Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France

• Main Authors: Bruno Bregman (Author), Siguroli Teitsson (Author), Isabella Orsini (Author), François-Emery Cotté (Author), Adenike Amadi (Author), Andriy Moshyk (Author), Stéphane Roze (Author), Anne-Françoise Gaudin (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction The aim of the current study is to estimate the cost-effectiveness of adjuvant treatment with nivolumab relative to clinically relevant comparators in adult patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection from a Fre...